샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777466

세계의 정밀 진단 시장

Precision Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 382 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

정밀 진단 세계 시장은 2030년까지 498억 달러에 달할 전망

2024년에 182억 달러로 추정되는 정밀 진단 세계 시장은 2024-2030년 분석 기간 동안 18.3%의 CAGR로 성장하여 2030년에는 498억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 유전자 검사는 CAGR 20.1%를 기록하며 분석 기간 종료시에는 263억 달러에 달할 것으로 예측됩니다. 소비자용 직접 검사 분야의 성장률은 분석 기간 동안 CAGR 14.9%로 추정됩니다.

미국 시장은 50억 달러로 추정, 중국은 CAGR 24.3%로 성장 예측

미국의 정밀 진단 시장은 2024년에 50억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 113억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 24.3%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 13.4%와 16.6%로 예측됩니다. 유럽에서는 독일이 CAGR 약 14.6%로 성장할 것으로 예측됩니다.

세계의 정밀 진단 시장 - 주요 동향과 촉진요인 정리

정밀 진단이 헬스케어의 미래를 재구성하는 이유는 무엇일까?

정밀진단은 분자 수준 또는 유전자 수준에서 질병을 정밀하게 검출할 수 있는 일련의 첨단 의료 기술을 말합니다. 기존 진단 방법과 달리 정밀진단은 유전자, 생활습관, 환경의 개인차에 주목하여 진단과 치료 전략을 환자 개개인에 맞게 조정합니다. 이러한 변화는 더 빠른 질병 식별, 더 나은 위험 계층화, 더 개별화된 치료 경로를 가능하게 하여 환자 결과를 크게 개선하고 치료의 비효율성을 줄일 수 있습니다.

암, 심혈관질환, 자가면역질환 등 복잡한 질환의 전 세계 유병률 증가로 인해 보다 정교한 진단 도구에 대한 수요가 증가하고 있습니다. 헬스케어 시스템이 예방과 가치 기반 치료로 진화하는 가운데, 정밀 진단은 이러한 변화의 핵심으로 부상하고 있습니다. 조기 발견, 예후 예측 및 모니터링에서 정밀 진단의 역할은 질병 부담을 줄일 뿐만 아니라 적시에 개입할 수 있도록 하는 것이며, 이는 만성적이고 생명을 위협하는 질병에 특히 중요합니다.

기술의 발전과 소비자의 기대가 시장에 어떤 영향을 미치고 있는가?

기술 혁신은 빠르게 상황을 발전시키고 있습니다. 유전체 시퀀싱, 분자 프로파일링, 바이오마커 분석 능력의 향상으로 질병을 치료 가능한 가장 초기에 발견할 수 있게 되었습니다. 인공지능과 머신러닝 기반 도구는 현재 패턴 인식을 강화하고 데이터 해석을 자동화하며 실시간 임상적 의사결정을 지원하고 있습니다. 이러한 획기적인 발전은 진단의 범위와 속도를 확장하고, 보다 효과적이고 확장 가능한 진단을 가능하게 합니다.

동시에 소비자의 행동은 정밀 진단이 어떻게 설계되고 제공되는지를 형성하고 있습니다. 오늘날의 환자들은 건강에 대한 이해도가 높고, 데이터에 대한 인식이 높으며, 개인화된 건강 솔루션에 적극적입니다. 액체 생검, 웨어러블 건강기기, 가정용 검사 키트 등 비침습적 검사 옵션에 대한 관심이 높아지고 있습니다. 이러한 변화는 의료 서비스 제공자 및 진단 의약품을 제공하는 기업들에게 정확성, 속도, 편의성, 프라이버시, 사용자 중심의 경험을 제공하도록 촉구하고 있습니다. 이러한 기대치의 진화는 제품 개발, 임상 워크플로우, 그리고 현대 의학에서 정밀 진단의 전반적인 위치에 영향을 미치고 있습니다.

정밀 진단 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다.

정밀 진단 시장의 성장은 종양학, 심장병학, 신경학, 감염학 분야의 진단 기술 적용 확대 등 몇 가지 요인에 의해 주도되고 있습니다. 실용적인 유전자 변이 및 바이오마커를 식별할 수 있게 됨에 따라 임상의는 치료를 조정하고 치료 효과를 보다 정확하게 모니터링할 수 있게 되었습니다. 이는 표적치료가 표준치료가 되고 있는 암 치료에서 특히 중요합니다.

또 다른 큰 원동력은 첨단 진단 기술의 비용과 복잡성이 줄어들어 진료소, 검사기관, 나아가 소비자들이 보다 쉽게 이용할 수 있게 되었다는 점입니다. 진단과 전자의무기록, 임상판단 지원 도구, 개별화 치료 알고리즘과의 통합은 의료 연계를 강화하고 오진을 줄이고 있습니다. 또한, 의료 기술 혁신에 대한 투자 증가와 맞춤형 의료에 대한 제도적 지원이 차세대 진단 플랫폼의 개발 및 보급을 촉진하고 있습니다. 이러한 요소들을 종합하면, 정밀진단은 헬스케어의 미래를 바꿀 수 있는 힘으로 자리매김하고 있습니다.

부문

검사 유형(유전자 검사, 소비자용 직접 검사, 에소테릭 검사, 기타 검사 유형), 용도(종양학 용도, 호흡기질환 용도, 피부질환 용도, 중추신경질환 용도, 면역학 용도, 유전질환 용도, 기타 용도), 최종 용도(임상 검사실최종 용도, 병원 최종 용도, 기타 최종 용도)

조사 대상 기업 사례

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Guardant Health
  • Hologic, Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Lantheus Holdings, Inc.
  • Myriad Genetics, Inc.
  • Novartis AG
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Swiss Precision Diagnostics GmbH
  • Thermo Fisher Scientific Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.05

Global Precision Diagnostics Market to Reach US$49.8 Billion by 2030

The global market for Precision Diagnostics estimated at US$18.2 Billion in the year 2024, is expected to reach US$49.8 Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2024-2030. Genetic Tests, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$26.3 Billion by the end of the analysis period. Growth in the Direct to Consumer Tests segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 24.3% CAGR

The Precision Diagnostics market in the U.S. is estimated at US$5.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 24.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.4% and 16.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Global Precision Diagnostics Market - Key Trends & Drivers Summarized

Why Is Precision Diagnostics Reshaping the Future of Healthcare?

Precision diagnostics refers to a set of advanced medical technologies that enable highly accurate disease detection, often at the molecular or genetic level. Unlike traditional diagnostic methods, precision diagnostics focuses on individual variability in genes, lifestyle, and environment to tailor diagnosis and treatment strategies to each patient. This shift allows for earlier disease identification, better risk stratification, and more personalized care pathways, significantly improving patient outcomes and reducing treatment inefficiencies.

The increasing global incidence of complex diseases such as cancer, cardiovascular conditions, and autoimmune disorders has accelerated the demand for more sophisticated diagnostic tools. As healthcare systems evolve toward prevention and value-based care, precision diagnostics is emerging as a cornerstone of this transformation. Its role in early detection, prognosis, and monitoring is not only reducing disease burden but also enabling timely intervention, which is especially critical for chronic and life-threatening conditions.

How Are Technological Advancements and Consumer Expectations Influencing the Market?

Technological innovation is rapidly advancing the precision diagnostics landscape. The growing capabilities of genomic sequencing, molecular profiling, and biomarker analysis have made it possible to detect diseases at their earliest and most treatable stages. Tools powered by artificial intelligence and machine learning are now enhancing pattern recognition, automating data interpretation, and supporting real-time clinical decision-making. These breakthroughs are expanding the scope and speed of diagnostics, making them more effective and scalable.

At the same time, consumer behavior is shaping how precision diagnostics are being designed and delivered. Today’s patients are more health-literate, data-conscious, and proactive about personalized health solutions. There's growing interest in non-invasive testing options such as liquid biopsies, wearable health devices, and home-based test kits. This shift is pushing healthcare providers and diagnostics companies to deliver more user-centric experiences that combine accuracy, speed, convenience, and privacy. These evolving expectations are influencing product development, clinical workflows, and the overall positioning of precision diagnostics in modern medicine.

The Growth in the Precision Diagnostics Market Is Driven by Several Factors……

The growth in the precision diagnostics market is driven by several factors, starting with the expanding application of diagnostic technologies across oncology, cardiology, neurology, and infectious diseases. The ability to identify actionable genetic mutations and biomarkers is enabling clinicians to tailor therapies and monitor treatment effectiveness with greater precision. This is particularly crucial in cancer treatment, where targeted therapies are becoming standard practice.

Another major driver is the reduction in cost and complexity of advanced diagnostic technologies, making them more accessible to clinics, labs, and even consumers. The integration of diagnostics with electronic health records, clinical decision support tools, and personalized treatment algorithms is enhancing care coordination and reducing misdiagnoses. Additionally, rising investment in health innovation and institutional support for personalized medicine is fostering the development and deployment of next-generation diagnostic platforms. Collectively, these factors are positioning precision diagnostics as a transformative force in the future of healthcare.

SCOPE OF STUDY:

The report analyzes the Precision Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Genetic Tests, Direct to Consumer Tests, Esoteric Tests, Other Test Types); Application (Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application, Immunology Application, Genetic Diseases Application, Other Applications); End-Use (Clinical Laboratories End-Use, Hospitals End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Guardant Health
  • Hologic, Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Lantheus Holdings, Inc.
  • Myriad Genetics, Inc.
  • Novartis AG
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Swiss Precision Diagnostics GmbH
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Precision Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Personalized Medicine Accelerates Growth in Precision Diagnostics
    • Surge in Chronic Disease Prevalence Drives Adoption of Precision Diagnostics Technologies
    • Technological Advancements in Genomic Sequencing Propel Growth in Precision Diagnostics Market
    • Rising Popularity of Preventive Healthcare Strengthens Business Case for Early Detection and Diagnostic Solutions
    • Integration of Artificial Intelligence in Diagnostics Expands Market Opportunities for Precision Diagnostics
    • Increasing Focus on Minimally Invasive Diagnostic Techniques Drives Adoption of Precision Diagnostics Solutions
    • Growing Demand for Point-of-Care Diagnostics Expands the Reach of Precision Diagnostic Technologies
    • Regulatory Support for Early Disease Detection Strengthens Demand for Precision Diagnostics in Healthcare Systems
    • Rising Healthcare Expenditure Globally Creates Growth Opportunities for Advanced Diagnostic Solutions
    • Growing Awareness of the Benefits of Precision Medicine and Targeted Treatments Drives Demand for Diagnostic Tools
    • Expansion of Healthcare Infrastructure in Emerging Markets Generates New Opportunities for Precision Diagnostics
    • Increasing Focus on Precision Diagnostics in Oncology Propels Market Growth in Cancer Detection and Monitoring
    • Surge in the Development of Companion Diagnostics Drives Growth in the Precision Diagnostics Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Precision Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Precision Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Genetic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Direct to Consumer Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Direct to Consumer Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Direct to Consumer Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Esoteric Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Esoteric Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Esoteric Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Genetic Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Respiratory Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Respiratory Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Respiratory Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Skin Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Skin Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Skin Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for CNS Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for CNS Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for CNS Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Immunology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Immunology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Immunology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Precision Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Precision Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Australia 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 179: India Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: India 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: South Korea 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Precision Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Latin America 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Argentina 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Brazil 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Mexico 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Precision Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Precision Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Middle East 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Iran 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Israel 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: UAE 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Precision Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Precision Diagnostics by Test Type - Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Precision Diagnostics by Test Type - Percentage Breakdown of Value Sales for Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Precision Diagnostics by Application - Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Precision Diagnostics by Application - Percentage Breakdown of Value Sales for Genetic Diseases Application, Other Applications, Oncology Application, Respiratory Diseases Application, Skin Diseases Application, CNS Disorders Application and Immunology Application for the Years 2015, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Precision Diagnostics by End-Use - Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Africa 15-Year Perspective for Precision Diagnostics by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories End-Use, Hospitals End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제